| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer E Kapiteijn, CAM Marijnen, ID Nagtegaal, H Putter, WH Steup, T Wiggers, ... New England Journal of Medicine 345 (9), 638-646, 2001 | 4355 | 2001 |
| ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making HJ Schmoll, E Van Cutsem, A Stein, V Valentini, B Glimelius, ... Annals of oncology 23 (10), 2479-2516, 2012 | 1274 | 2012 |
| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial W van Gijn, CAM Marijnen, ID Nagtegaal, EMK Kranenbarg, H Putter, ... The lancet oncology 12 (6), 575-582, 2011 | 1268 | 2011 |
| The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma KCMJ Peeters, CAM Marijnen, ID Nagtegaal, EK Kranenbarg, H Putter, ... Annals of surgery 246 (5), 693-701, 2007 | 1165 | 2007 |
| What is the role for the circumferential margin in the modern treatment of rectal cancer? ID Nagtegaal, P Quirke Journal of Clinical Oncology 26 (2), 303-312, 2008 | 983 | 2008 |
| Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ... The Journal of pathology 232 (2), 199-209, 2014 | 877 | 2014 |
| Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit ID Nagtegaal, CAM Marijnen, EK Kranenbarg, CJH van de Velde, ... The American journal of surgical pathology 26 (3), 350-357, 2002 | 858 | 2002 |
| Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. ID Nagtegaal, CJH van de Veld, E Worp, E Kapiteijn, P Quirke, ... | 786 | 2002 |
| Low rectal cancer: a call for a change of approach in abdominoperineal resection. ID Nagtegaal, CJ Van de Velde, CA Marijnen, JHJM van Krieken, ... | 674 | 2005 |
| Cancer classification using the Immunoscore: a worldwide task force J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ... Journal of translational medicine 10 (1), 1-10, 2012 | 617 | 2012 |
| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 542 | 2018 |
| BRAF mutation in metastatic colorectal cancer. J Tol, ID Nagtegaal, CJA Punt | 506 | 2009 |
| Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis G Litjens, CI Sánchez, N Timofeeva, M Hermsen, I Nagtegaal, I Kovacs, ... Scientific reports 6, 26286, 2016 | 494 | 2016 |
| No downstaging after short-term preoperative radiotherapy in rectal cancer patients. CA Marijnen, ID Nagtegaal, E Meershoek-Klein Kranenbarg, J Hermans, ... | 416 | 2001 |
| EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum CJH van de Velde, PG Boelens, JM Borras, JW Coebergh, A Cervantes, ... European journal of cancer 50 (1), 1. e1-1. e34, 2014 | 359 | 2014 |
| Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies S Venderbosch, ID Nagtegaal, TS Maughan, CG Smith, JP Cheadle, ... Clinical Cancer Research 20 (20), 5322-5330, 2014 | 335 | 2014 |
| Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution DC Allred, Y Wu, S Mao, ID Nagtegaal, S Lee, CM Perou, SK Mohsin, ... Clinical cancer research 14 (2), 370-378, 2008 | 319 | 2008 |
| Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial CAM Marijnen, ID Nagtegaal, E Kapiteijn, EK Kranenbarg, EM Noordijk, ... International Journal of Radiation Oncology* Biology* Physics 55 (5), 1311-1320, 2003 | 319 | 2003 |
| Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 A Lugli, R Kirsch, Y Ajioka, F Bosman, G Cathomas, H Dawson, ... Modern pathology 30 (9), 1299-1311, 2017 | 285 | 2017 |
| Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor–positive ductal carcinoma in situ: a study based on NSABP protocol B-24 DC Allred, SJ Anderson, S Paik, DL Wickerham, ID Nagtegaal, SM Swain, ... Journal of Clinical Oncology 30 (12), 1268, 2012 | 268 | 2012 |
